Development of world first BARD1 Breast Cancer Test
Filed with ASX · · 5 pages · English
Earlier from Inoviq
- Bard1 Ovarian Test Results
- Appendix 4E
- Quarterly Activities Report and Appendix 4C
- US Patent Issued Protecting BARD1 Ovarian Test
- Improved Performance of BARD1 Ovarian Test
Later from Inoviq
- Grant of Additional Chinese Patent Core BARD1 Patent Family
- Quarterly Activities Report and Cashflow
- Pause In Trading
- Non-Renounceable Issue
- Capital Raising Indicative Timetable
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq